A.G. den Hartog

772 citations
23 papers · 512 indexed · 1 hit paper · h-index 13
Topics
Cerebrovascular and Carotid Artery Diseases (19 papers)Cardiovascular Health and Disease Prevention (16 papers)Acute Ischemic Stroke Management (7 papers)

In The Last Decade

A.G. den Hartog

21 papers receiving 507 citations

Hit Papers

Neoadjuvant nivolumab and relatlimab in locally advanced ...202420262025202410203040

Peers

A.G. den Hartog
Comparison fields: 5 of 45
  • Pulmonary and Respiratory Medicine 422
  • Cardiology and Cardiovascular Medicine 293
  • Epidemiology 197
  • Neurology 125
  • Radiology, Nuclear Medicine and Imaging 76
Replace L. L. H. Wu with:
L. L. H. Wu China
Mark W. Moritz United States
Ke Lin United States
Anouk C. van Dijk Netherlands
Outi Pelkonen Finland
Andrew M. Bakken United States
Rafał Badacz Poland
Servando Cardona Germany
Benjamin Sandholt Denmark
Andrey Pavlov United States
A.G. den Hartog relative to L. L. H. Wu China L. L. H. Wu's profile →
Citations per field
00.5×4.9×
L. L. H. Wu · 1×
Citations per year

Countries citing papers authored by A.G. den Hartog

Since Specialization
Citations

This map shows the geographic impact of A.G. den Hartog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.G. den Hartog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.G. den Hartog more than expected).

Fields of papers citing papers by A.G. den Hartog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.G. den Hartog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.G. den Hartog. The network helps show where A.G. den Hartog may publish in the future.

Co-authorship network of co-authors of A.G. den Hartog

This figure shows the co-authorship network connecting the top 25 collaborators of A.G. den Hartog. A scholar is included among the top collaborators of A.G. den Hartog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.G. den Hartog. A.G. den Hartog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trialbreakdown →
40
3 1
4 10
5 16
6 19
7 12
8 15
9 12
10 7
11 88
12 76
13 0
14 33
15 22
16 9
17 7
18 1
19 34
20 5

About A.G. den Hartog

A.G. den Hartog is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Rheumatology, having authored 23 papers that have together received 512 indexed citations. Recurring topics across this work include Cerebrovascular and Carotid Artery Diseases (19 papers), Cardiovascular Health and Disease Prevention (16 papers) and Acute Ischemic Stroke Management (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (422 citations), Cardiology and Cardiovascular Medicine (293 citations) and Neurology (125 citations). A.G. den Hartog has collaborated with scholars based in Netherlands, United Kingdom and Israel. Frequent co-authors include Gert J. de Borst, Frans L. Moll, Margriet Fokkema, Ale Algra, Gerard Pasterkamp, Michiel L. Bots, Sefanja Achterberg, Ingeborg van der Tweel, Jeroen Hendrikse and L. Jaap Kappelle. Their work appears in journals such as Nature Medicine, Stroke and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026